This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Mixed Depression, Suicidality, and Antidepressants

Franco Benazzi, MD, PhD

Published: October 16, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The important article by Bauer et al.1 showed no association between antidepressants and suicidality in bipolar depression. However, among the correlates of suicidality, intradepression manic symptoms at intake, before antidepressant treatment was started, increased the odds ratio of suicidality to 1.62. The article seems to underplay this important finding, given the recent warning of the U.S. Food and Drug Administration (FDA)2 about the need to monitor patients during antidepressant treatment for the emergence of possible precursors to suicidality, including manic symptoms such as irritability and psychomotor agitation, which are common intradepression manic symptoms.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Depression (MDD) , Suicide

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...